-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$48.8645.5% Upside
Harmony Biosciences Holdings, Inc. Frequently Asked Questions
-
What analysts cover Harmony Biosciences Holdings, Inc.?
Harmony Biosciences Holdings, Inc. has been rated by research analysts at Goldman Sachs, Mizuho Securities, UBS, Oppenheimer, Needham, Raymond James in the past 90 days.